Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says
Adds shortage details in paragraph 3, details on HHS response in paragraph 9, 10
Oct 9 (Reuters) -The closure of Baxter International's BAX.N North Cove facility in North Carolina following Hurricane Helene could further limit the supply of intravenous fluids, the U.S. Department of Health and Human Services said on Wednesday.
The company, one of the four main U.S. suppliers of IV fluids, had on Sept. 29 said production at the site has been shut due to flooding. It added it was working with the government to assess the damage and bring the plant back online.
On Tuesday, the U.S Food and Drug Administration said two doses of Baxter's Dextrose solutions for low blood sugar and a saline solution are in shortage.
Meanwhile, HHS said it has also considered the possibility of Hurricane Milton further disrupting the IV fluid supply chain and was working to move the product away from the projected path of the storm.
Baxter has said it aims to restart production in phases and return to 90% to 100% allocation of certain IV solutions by the end of 2024.
The company said it was also increasing the U.S. allocation of its highest demand IV fluids for direct customers to 60% from 40% and for distributors to 60% from 10%, effective Oct. 9.
Germany's Fresenius FREG.DE said on Tuesday it was checking options to start new infusion-solution production lines faster than planned at a North Carolina facility to help mitigate the potential shortages.
The U.S. health department said it is working with other domestic IV solutions manufacturers to combat the supply crunch.
Reporting by Christy Santhosh in Bengaluru; Editing by Leroy Leo, Arun Koyyur and Sriraj Kalluvila
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
